• 首页
  • 关于期刊
    期刊简介
    编委会
    青年编委会
    合作单位
    《药学研究》编辑部
  • 投稿指南
  • 制度与声明
    出版伦理规范
    学术不端声明
    开放获取(OA)声明
    AIGC工具使用声明
  • 期刊订阅
  • 下载中心
  • English
引用本文:伍振辉,吴敏,高姚,梁祯尧,吴欣平,周露,袁秋平,刘凡,曾英坚.姜黄素及其衍生物在急性髓系白血病治疗中的研究进展[J].药学研究,2026,45(5):542-551[点击复制]
【打印本页】      【下载PDF全文】   【查看/发表评论】  【下载PDF阅读器】  【关闭】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 1783次   下载 796次 本文二维码信息
码上扫一扫!
姜黄素及其衍生物在急性髓系白血病治疗中的研究进展
伍振辉,吴敏,高姚,梁祯尧,吴欣平,周露,袁秋平,刘凡,曾英坚
字体:加大+|默认|缩小-
(江西中医药大学附属医院血液科,江西 南昌 330006)
摘要:
急性髓系白血病(AML)是一种高度侵袭性的恶性血液肿瘤疾病,因其复杂的病理机制和高复发率,给临床治疗带来了巨大挑战。姜黄素,作为一种来源于天然植物姜黄的多酚类化合物,因其多靶点、多机制的抗癌特性,近年来在AML治疗领域引起广泛关注。本文系统综述了姜黄素及其衍生物在AML中的研究进展,重点阐述了其通过诱导凋亡、诱导焦亡、调节自噬、逆转多药耐药、抑制免疫逃逸、表观遗传调控、诱导铁死亡的作用机制。同时,探讨了姜黄素与传统化疗药物的协同增效作用及其衍生物在提升疗效的应用,并针对当前研究的局限性分析了实现临床转化所面临的挑战,强调了药物联合增敏减毒和开展大规模临床试验的必要性。本综述旨在为姜黄素相关抗AML治疗策略的深入研究和临床应用提供理论依据和参考。
关键词:  急性髓系白血病  姜黄素  姜黄素及其衍生物  姜黄素联合  药理作用
DOI:10.13506/j.cnki.jpr.2026.05.010
基金项目:国家自然科学基金项目(No.82305159、82260914)
收稿日期:2025-11-11   修回日期:2025-12-04   出版日期:2026-05-29
Research progress of curcumin and its derivatives in treatment of acute myeloid leukemia
WU Zhenhui,WU Min,GAO Yao,LIANG Zhenyao,WU Xinping,ZHOU Lu,YUAN Qiuping,LIU Fan,ZENG Yingjian
(Department of Hematology, Jiangxi University of Chinese Medicine Affiliated Hospital, Nanchang 330000,China)
Abstract:
Acute myeloid leukemia (AML) is a highly aggressive hematological malignancy. Its complex pathological mechanisms and high recurrence rate pose significant challenges to clinical treatment. Curcumin, a polyphenolic compound derived from the natural plant Curcuma longa, has attracted widespread attention in AML treatment in recent years due to its multi-targeted and multi-mechanistic anticancer properties. This article systematically reviews the research progress of curcumin and its derivatives in AML, focusing on elaborating their mechanisms of action, including inducing apoptosis, triggering pyroptosis, regulating autophagy, reversing multidrug resistance, inhibiting immune escape, mediating epigenetic regulation, and inducing ferroptosis. Meanwhile, it discusses the synergistic efficacy-enhancing effects of curcumin with traditional chemotherapeutic drugs and the application of its derivatives in improving therapeutic efficacy. Additionally, it analyzes the challenges for clinical translation based on the limitations of current research, emphasizing the necessity of drug combination for sensitization and toxicity reduction, as well as the conduction of large-scale clinical trials. This review aims to provide a theoretical basis and reference for in-depth research and clinical application of curcumin-related anti-AML therapeutic strategies.
Key words:  Acute myeloid leukemia  Curcumin  Curcumin and its derivatives  Curcumin combination  Pharmacological activities
今日访问量:2656    总访问量:55339172
网站版权:《药学研究》编辑部     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
主办:山东省食品药品检验研究院、山东省药学会 地址:山东省济南市高新区新泺大街2749号 邮政编码:250101
电话:0531-81216586 电子邮箱:yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
技术支持:北京勤云科技有限公司